The Human Proteome Organization (HUPO) and BGI (formerly the Beijing Genomics Institute) have proposed large-scale projects to characterize the human proteome. Is this an important priority for the scientific community?​

In a previous issue of Clinical Chemistry, experts discussed large-scale proteomics efforts in this Q&A by Andrew N. Hoofnagle, et al. (free to access). We’d like to hear what you have to say about this topic.

Share your opinion on this topic below. Be sure to check out all of our Q&As here.​​​​